First Light Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

First Light Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.6M	Sell	1,001,846 -571,855	-36%	-$16.5M	2.83%	12
2025 Q4	$39.1M	Buy	1,573,701 +158,707	+11%	+$3.19M	2.99%	11
2025 Q3	$23M	Sell	1,414,994 -299,025	-17%	-$4.24M	2.16%	18
2025 Q2	$22.5M	Sell	1,714,019 -138,271	-7%	-$1.99M	2.91%	13
2025 Q1	$40.8M	Buy	1,852,290 +1,071,651	+137%	+$28.1M	4.65%	8
2024 Q4	$20.8M	Buy	+780,639	New	+$24.9M	1.99%	18

Other funds holding EWTX

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

First Light Asset Management's EWTX Position: Q1 2026 in Review

First Light Asset Management reduced its Edgewise Therapeutics (EWTX) stake by 36% in Q1 2026, selling an estimated $16.5M and leaving 1,001,846 shares worth $31.6M. The position accounts for 2.83% of the portfolio, ranked #12.

First Light Asset Management first reported a position in EWTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $40.8M in Q1 2025. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

First Light Asset Management held 1,001,846 shares of Edgewise Therapeutics worth $31.6M as of Q1 2026.
First Light Asset Management sold 571,855 Edgewise Therapeutics shares in Q1 2026, an estimated $16.5M.
Edgewise Therapeutics made up 2.83% of First Light Asset Management's portfolio in Q1 2026, its #12 holding.
First Light Asset Management first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 6 quarters since.
First Light Asset Management's Edgewise Therapeutics position peaked at $40.8M in Q1 2025.
214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on First Light Asset Management's 13F filing for Q1 2026, filed 15 May 2026.